The FDA just Approved Gene Therapy For Blindness
The Food and Drug Administration (FDA) approved the First Gene Therapy For Blindness in the US on Tuesday-Luxturna of Spark Therapeutics, which treats a form of hereditary vision loss that can lead to blindness. Researchers have been working for decades …